{"title":"USP41通过Notch1激活调节胶质瘤恶性:来自体外和体内研究的见解","authors":"Zhifeng Zhang, Siyu Zhu, Ziwei Wang, Hao Tong, Aobo Zhang, Shiyang Zhang, Liqiang Liu","doi":"10.1016/j.prp.2025.156217","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Glioma is the most prevalent and lethal primary adult central nervous system tumor, with limited therapeutic advances despite extensive research. The ubiquitin-proteasome system (UPS), particularly ubiquitin-specific proteases (USPs), plays critical roles in tumorigenesis. USP41, a member of the USP family, is implicated in multiple cancer types, but its function in glioma remains poorly understood. This study aimed to investigate the expression, biological functions, and underlying molecular mechanisms of USP41 in glioma cells and tissues, providing insights for targeted therapies.</div></div><div><h3>Methods</h3><div>USP41 expression levels were examined in clinical glioma specimens, normal brain tissues, and cell lines using qPCR and Western blotting. Bioinformatics analysis was conducted using the GEPIA database and KEGG enrichment to identify related signaling pathways. Functional assays, including CCK-8, EdU, colony formation, Transwell migration/invasion, wound healing, flow cytometry, and a xenograft model, were employed to evaluate proliferation, migration, invasion, apoptosis, and tumor growth. The role of Notch1 signaling in USP41-mediated glioma regulation was assessed through pharmacological activation (Jagged-1).</div></div><div><h3>Results</h3><div>USP41 expression was upregulated in glioma tissues and cell lines and associated with poorer survival. USP41 knockdown significantly inhibited glioma cell proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT), while promoting apoptosis in vitro. In vivo, USP41 knockdown reduced tumor size and weight. Mechanistic studies suggested that USP41 enhances glioma progression via the Notch1 pathway.</div></div><div><h3>Conclusions</h3><div>USP41 is a key regulator of glioma growth and invasiveness through Notch1 signaling. Targeting USP41 may represent a promising therapeutic strategy for improving glioma outcomes.</div></div>","PeriodicalId":19916,"journal":{"name":"Pathology, research and practice","volume":"275 ","pages":"Article 156217"},"PeriodicalIF":3.2000,"publicationDate":"2025-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"USP41 regulates glioma malignancy through Notch1 activation: Insights from in vitro and in vivo studies\",\"authors\":\"Zhifeng Zhang, Siyu Zhu, Ziwei Wang, Hao Tong, Aobo Zhang, Shiyang Zhang, Liqiang Liu\",\"doi\":\"10.1016/j.prp.2025.156217\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Glioma is the most prevalent and lethal primary adult central nervous system tumor, with limited therapeutic advances despite extensive research. The ubiquitin-proteasome system (UPS), particularly ubiquitin-specific proteases (USPs), plays critical roles in tumorigenesis. USP41, a member of the USP family, is implicated in multiple cancer types, but its function in glioma remains poorly understood. This study aimed to investigate the expression, biological functions, and underlying molecular mechanisms of USP41 in glioma cells and tissues, providing insights for targeted therapies.</div></div><div><h3>Methods</h3><div>USP41 expression levels were examined in clinical glioma specimens, normal brain tissues, and cell lines using qPCR and Western blotting. Bioinformatics analysis was conducted using the GEPIA database and KEGG enrichment to identify related signaling pathways. Functional assays, including CCK-8, EdU, colony formation, Transwell migration/invasion, wound healing, flow cytometry, and a xenograft model, were employed to evaluate proliferation, migration, invasion, apoptosis, and tumor growth. The role of Notch1 signaling in USP41-mediated glioma regulation was assessed through pharmacological activation (Jagged-1).</div></div><div><h3>Results</h3><div>USP41 expression was upregulated in glioma tissues and cell lines and associated with poorer survival. USP41 knockdown significantly inhibited glioma cell proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT), while promoting apoptosis in vitro. In vivo, USP41 knockdown reduced tumor size and weight. Mechanistic studies suggested that USP41 enhances glioma progression via the Notch1 pathway.</div></div><div><h3>Conclusions</h3><div>USP41 is a key regulator of glioma growth and invasiveness through Notch1 signaling. Targeting USP41 may represent a promising therapeutic strategy for improving glioma outcomes.</div></div>\",\"PeriodicalId\":19916,\"journal\":{\"name\":\"Pathology, research and practice\",\"volume\":\"275 \",\"pages\":\"Article 156217\"},\"PeriodicalIF\":3.2000,\"publicationDate\":\"2025-09-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pathology, research and practice\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0344033825004108\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PATHOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pathology, research and practice","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0344033825004108","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PATHOLOGY","Score":null,"Total":0}
USP41 regulates glioma malignancy through Notch1 activation: Insights from in vitro and in vivo studies
Background
Glioma is the most prevalent and lethal primary adult central nervous system tumor, with limited therapeutic advances despite extensive research. The ubiquitin-proteasome system (UPS), particularly ubiquitin-specific proteases (USPs), plays critical roles in tumorigenesis. USP41, a member of the USP family, is implicated in multiple cancer types, but its function in glioma remains poorly understood. This study aimed to investigate the expression, biological functions, and underlying molecular mechanisms of USP41 in glioma cells and tissues, providing insights for targeted therapies.
Methods
USP41 expression levels were examined in clinical glioma specimens, normal brain tissues, and cell lines using qPCR and Western blotting. Bioinformatics analysis was conducted using the GEPIA database and KEGG enrichment to identify related signaling pathways. Functional assays, including CCK-8, EdU, colony formation, Transwell migration/invasion, wound healing, flow cytometry, and a xenograft model, were employed to evaluate proliferation, migration, invasion, apoptosis, and tumor growth. The role of Notch1 signaling in USP41-mediated glioma regulation was assessed through pharmacological activation (Jagged-1).
Results
USP41 expression was upregulated in glioma tissues and cell lines and associated with poorer survival. USP41 knockdown significantly inhibited glioma cell proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT), while promoting apoptosis in vitro. In vivo, USP41 knockdown reduced tumor size and weight. Mechanistic studies suggested that USP41 enhances glioma progression via the Notch1 pathway.
Conclusions
USP41 is a key regulator of glioma growth and invasiveness through Notch1 signaling. Targeting USP41 may represent a promising therapeutic strategy for improving glioma outcomes.
期刊介绍:
Pathology, Research and Practice provides accessible coverage of the most recent developments across the entire field of pathology: Reviews focus on recent progress in pathology, while Comments look at interesting current problems and at hypotheses for future developments in pathology. Original Papers present novel findings on all aspects of general, anatomic and molecular pathology. Rapid Communications inform readers on preliminary findings that may be relevant for further studies and need to be communicated quickly. Teaching Cases look at new aspects or special diagnostic problems of diseases and at case reports relevant for the pathologist''s practice.